High Purity Pharmaceutical Grade 877399-52-5 Crizotinib for Anti-cancer Treatment
Sehlahisoalebitso | Crizotinib |
Litlhaloso tse tšoanang | PF-02341066;3- [(1R)-1-(2,6-Dichloro-3-fluorophenyl) ethoxy]-5-[1-(4-piperidinyl)-1H-pyrazol-4-yl]pyridin-2-amine;PF 2341066 |
Nomoro ea CAS. | 877399-52-5 |
Ponahalo | Phofo ea kristale e tšoeu ho isa bosoeu |
Foromo ea limolek'hule | C21H22Cl2FN5O |
Boima ba Molek'hule | 450.34 |
Tšebeliso | Pharmaceutical Grade kapa Research morero |
Ho paka | Joalo ka kopo ea hau |
Polokelo | Boloka ka lijaneng tse thata, tse sa keneleng khanya sebakeng se phodileng |
CrizotinibCas: 877399-52-5 | ||
Lintho | Litlhaloso | Liphetho |
Ponahalo | Phofo ea kristale e tšoeu ho isa bosoeu | Phofo e tšoeu ea kristale |
Boitsebiso | H-NMR, MS | E lumellana |
Metsoako e setseng | isopropanol≤0.5% EtOAc≤0.5% THF≤0.072% n-Heptane≤0.5% Toluene≤0.5% | 0.3% ND ND ND ND ND |
Litšepe tse boima | ≤10ppm | E lumellana |
Likahare tsa metsi | £0.5% | 0.3% |
Masalla ha a tuka | £0.5% | 0.05% |
Enantiomer | £0.1% | <LOQ |
Litšila tse Amanang le HPLC | Ho se hloeke ho le mong≤0.1% Ho se hloeke hohle ≤1.0% | 0.05% 0.12% |
Purity (HPLC) | ³99.0% | 99.88% |
Lintlha tsa Khampani
√ Boiphihlelo bo felletseng ba Management layer ho balateli ba lifeme le litsebi tse nang le boiphihlelo; √ Boleng ke kamehla ho nahanela rona holimo, Strict QC tsamaiso; √ lilemo tse 11 tse nang le boiphihlelo sehlopheng sa thekiso ea thepa kantle ho naha; √ Lab e ikemetseng ya R&D; √ Lithupelo tse peli tsa nako e telele tsa GMP; √ Lisebelisoa tse ruileng tsa lifeme tse ngata tse sa sebetseng bakeng sa morero o hlophisitsoeng; √ Sehlopha se sebetsang se sebetsang hantle se nang le tsela e tsitsitseng.Ngola molaetsa wa hao mona mme o re romele wona